ArticleCancers2022

Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I-II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study.

Sebastian Podlipnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.